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Abstract	  
A	  synthetic	  modular	  methodology	  allows	  the	  preparation	  of	  catalytic	  materials	  based	  
on	  magnetic	  nanoparticles	  with	  iridium-­‐N-­‐heterocyclic	  carbene	  (NHC)	  complexes.	  The	  
preparation	  of	   imidazolium	  salts	  containing	  a	  ketone/aldehyde	  as	  pendant	   functional	  
groups	   are	   the	   key	   species.	   The	   condensation	   reaction	   of	   the	   Cp*IrNHC-­‐CHO	  
compound	  with	  magnetic	  nanoparticles	  containing	  amine	  groups	  on	  the	  surface	  yields	  
the	   covalent	   anchoring	   of	   the	   iridium	   complex	   to	   the	   surface	   of	   the	  magnetite.	   The	  
catalytic	   properties	   have	   been	   evaluated	   in	   transfer	   hydrogenation.	   The	   iridium	  
complexes	  and	  the	  material	  are	  active	  in	  the	  reduction	  of	  ketones	  using	  isopropanol	  as	  
solvent	  and	  hydrogen	  donor.	  The	  catalytic	   results	   reveal	   that	   the	  catalytic	  activity	  of	  
the	   material	   and	   the	   molecular	   complex	   is	   equivalent.	   We	   have	   not	   observed	   any	  
change	   in	   activity	   due	   to	   the	   support.	   The	   recyclability	   properties	   of	   the	   magnetic	  
material	  have	  been	  evaluated.	  The	  results	  show	  that	  the	  catalyst	  activity	  is	  maintained	  
for	  two	  runs.	  This	  work	  describes	  a	  simple	  methodology	  for	  the	  anchoring	  of	  molecular	  
complexes	  on	  the	  surface	  of	  magnetic	  nanoparticles.	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The	  green	  chemistry	  definition	  proposed	  by	  Anastas	  and	  Warner1	  as	  “the	  utilization	  of	  
a	   set	   of	   principles	   that	   reduces	   or	   eliminates	   the	   use	   or	   generation	   of	   hazardous	  
substances	   in	   the	   design,	   manufacture	   and	   application	   of	   chemical	   products”	   has	  
encouraged	   the	   scientific	   community	   to	   look	   for	   efficient	   ways	   to	   separate	  
homogenous	   catalysts	   from	   the	   reaction	  media	  and	   their	   subsequent	   recycling.2	   The	  
use	  of	  magnetic	  nanoparticles	  (MNPs)	  as	  efficient	  supports	  for	  catalysts	  has	  become	  a	  
subject	   of	   intense	   investigation.3	   The	  MNPs	   offer	   advantages	   in	   the	   development	   of	  
clean	   and	   sustainable	   green	   processes	   as	   they	   are	   non-­‐toxic,	   4	   easy-­‐accessible,	   5	  
retrievable	   and	   reusable.6	   In	   the	   last	   years,	   two	   seminal	  manuscripts	   describing	   the	  
immobilization	  of	  ruthenium	  catalyst	  have	  been	  described	  (Chart	  1).	  The	  Noyori	   type	  
catalyst	  was	   immobilized	  over	  MNPs	  using	  a	  phosphoric	  acid-­‐substituted	  BINAP	  (2,2'-­‐
bis(diphenylphosphino)-­‐1,1'-­‐binaphthyl).	  The	  MNPs-­‐Ru-­‐BINAP	  chiral	  material	  catalyzed	  
the	  asymmetric	  hydrogenation	  of	  aromatic	  ketones	  in	  quantitative	  yields	  and	  excellent	  
enantioselectivities.	  The	  system	  could	  be	  recycled	  by	  magnetic	  decantation	  and	  reused	  
for	  up	  14	  times	  without	  loss	  of	  activity	  and	  enantioselectivity.7	  The	  second	  generation	  
Hoveyda-­‐Gurbbs	   catalyst	   has	   been	   immobilized	   on	   surface	   modify	   magnetite	  
nanoparticles	  by	  a	  divergent	  synthetic	  approach.	  The	  catalytic	  system	  is	  high	  effective	  
for	  self-­‐	  and	  cross-­‐metathesis	  reactions	  of	  methyl	  oleate	  and	  could	  be	  easily	  separated	  
by	  magnetic	  attraction.8	  
 
Chart	  1	  Noyori	  and	  Hoveyda-­‐Grubbs	  catalysts	  immobilization	  strategies	  
The	   main	   advantages	   of	   homogeneous	   catalysis	   are	   selectivity	   and	   easy	   tuning	   of	  
properties	  by	  ligand	  modification.	  In	  contrast,	  the	  main	  drawback	  is	  catalyst	  separation	  
from	  the	  final	  reaction	  product.9	  Whilst	  for	  many	  processes	  small	  amount	  of	  metals	  is	  
not	   a	   problem,	   just	   traces	   of	  metals	   become	   really	   important	   in	   the	   pharmaceutical	  
industry.	  Using	  heterogeneous	  catalyst	  systems,	  separation	   is	  not	  a	  problem,	  as	   they	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can	  be	  easily	  removed	  by	  simple	  filtration.	  The	  problem	  arises	  mostly	  from	  selectivity.	  
Over	  the	  last	  decade	  the	  use	  of	  magnetic	  nanoparticles	  functionalized	  with	  transition	  
metal	   for	  applications	   in	  catalysis	  has	  expanded	  considerably.10	  Most	  of	   the	  catalytic	  
materials	  obtained	  lack	  of	  a	  general	  synthetic	  method	  for	  the	  preparation	  of	  different	  
metal	   complexes.	   In	   this	   work	   we	   describe	   a	   modular	   approach	   method	   for	  
development	   of	   catalytic	  materials	   based	   on	  magnetic	   nanoparticles	   decorated	  with	  
metal-­‐N-­‐heterocyclic	   carbene	   (NHC)	   complexes.11	   The	   metal-­‐NHC	   based	   complexes	  
have	   demonstrated	   their	  wide	   scope	   application	   in	   catalysis,	   and	   their	   usefulness	   in	  
the	  synthesis	  of	  complex	  natural	  products	  and	  valuable	  molecules.12	  The	  NHC	  ligands	  
confer	   a	   high	   stability	   to	   the	  metal	   and	   act	   as	   spectator	   ligands.13	   These	   important	  
characteristics	   make	   NHC	   ligands	   good	   candidates	   for	   the	   preparation	   of	   reusable	  
magnetite	  based-­‐catalysts.	  	  
In	   the	  course	  of	  our	   research	  we	  have	  developed	  efficient	   catalysts	  based	  on	  
metal-­‐NHC	  complexes	  for	  transfer	  hydrogenation.14	  On	  the	  basis	  of	  previous	  results	  we	  
now	  described	  the	  synthesis	  of	  magnetic	  nanoparticles	  functionalized	  with	  iridium	  N-­‐
heterocyclic	   carbene	   complexes	   (NHCs)	   for	   the	   preparation	   of	   advanced	   catalytic	  
materials	  that	  would	  be	  reusable	  and	  retrievable	  from	  the	  reaction	  mixture	  by	  simple	  
decantation	  using	  an	  external	  magnet.	  
	  
Experimental	  
Materials	  and	  methods	  
All	  manipulations	  were	  carried	  out	  under	  aerobic	  conditions	  unless	  otherwise	  stated.	  
The	  4ʹ′-­‐(Imidazol-­‐1-­‐yl)acetophenone	  and	  Fe3O4	  magnetic	  nanoparticles	  were	  purchased	  
from	  commercial	  suppliers.	  The	   imidazolium	  salt	  115,	  4-­‐(chloromethyl)benzaldehyde16	  
and	   functionalized	   Fe3O4	   magnetic	   nanoparticles17	   were	   prepared	   according	   to	  
literature	   procedures.	   Anhydrous	   solvents	   were	   dried	   using	   a	   solvent	   purification	  
system	  (SPS	  M	  BRAUN)	  or	  purchased	  from	  purchased	  from	  commercial	  suppliers	  and	  
degassed	   prior	   to	   use	   by	   purging	  with	   dry	   nitrogen	   and	   kept	   over	  molecular	   sieves.	  
NMR	  spectra	  were	  recorded	  on	  Varian	  Innova	  spectrometers	  operating	  at	  300	  or	  500	  
MHz	  (1H	  NMR)	  and	  75	  and	  125	  MHz	  (13C	  NMR),	  respectively,	  using	  CDCl3	  as	  solvent	  at	  
room	  temperature	  unless	  otherwise	  stated.	  Elemental	  analyses	  were	  carried	  out	  in	  an	  
EA	   1108	   CHNS-­‐O	   Carlo	   Erba	   analyzer.	   Electrospray	   mass	   spectra	   (ESI-­‐MS)	   were	  
recorded	  on	  a	  Micromass	  Quatro	  LC	  instrument,	  and	  nitrogen	  was	  employed	  as	  drying	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and	   nebulizing	   gas.	   Infrared	   spectra	   (FTIR)	   were	   recorded	   on	   a	   JASCO	   FTIR-­‐6200	  
spectrometer	  with	  aspectral	  window	  of	  4000-­‐500	  cm-­‐1.	  High	   resolution	   transmission	  
electron	  microscopy	   images	   (HRTEM)	  and	  high-­‐angle	  annular	  dark-­‐ﬁeld	  HAADF-­‐STEM	  
images	   of	   the	   samples	   were	   obtained	   using	   a	   Jem-­‐2100	   LaB6	   (JEOL)	   transmission	  
electron	  microscope	  coupled	  with	  an	  INCA	  Energy	  TEM	  200	  (Oxford)	  energy	  dispersive	  
X-­‐Ray	   spectrometer	   (EDX)	   operating	   at	   200	   kV.	   The	   crystallographic	   structure	   of	   the	  
samples	  was	  analyzed	  by	  X-­‐ray	  powder	  diffraction	   (XRD)	  using	  a	  Bruker	  D4-­‐Endeavor	  
diffractometer	   with	   a	   Cu-­‐K	   radiation	   with	   a	   wavelength	   of	   0.1542	   nm.	   The	  
determination	   of	   the	   metal	   loading	   was	   done	   by	   ICP–MS	   Agilent	   7500	   CX.	   The	  
digestion	   of	   the	   samples	  was	   carried	   out	   under	   reflux	   of	   a	  mixture	   of	   concentrated	  
nitric	   and	   hydrochloric	   acids	   (3:1)	   for	   12	   h.	   The	   digestion	   of	   the	   samples	   after	   the	  
recycling	  experiments	  were	  carried	  out	  after	  several	  washes	  with	  milli-­‐Q	  water	  (10	  x	  10	  
mL).	  
Crystallography	  
X-­‐ray	   studies:	   Diffraction	   data	   was	   collected	   on	   a	   Agilent	   SuperNova	   diffractometer	  
equipped	  with	   an	   Atlas	   CCD	   detector	   using	  Mo-­‐Kα	   radiation	   (λ =	   0.71073	   Å).	   Single	  
crystals	   were	   mounted	   on	   a	   polymer	   tip	   in	   a	   random	   orientation.	   Absorption	  
corrections	  based	  on	  the	  multiscan	  method	  were	  applied.18	  The	  structures	  were	  solved	  
by	   direct	  methods	   in	   SHELXS-­‐97	   and	   refined	   by	   the	   full-­‐matrix	  method	   based	   on	   F2	  
with	  the	  program	  SHELXL-­‐97	  using	  the	  OLEX	  software	  package.19	  
Synthetic	  procedures	  
Synthesis	  of	  2.	  To	  a	  solution	  of	  4ʹ′-­‐(imidazol-­‐1-­‐yl)acetophenone	  (476	  mg,	  2.56	  mmol)	  in	  
methanol	   (5	  mL)	  was	   added	  1-­‐Bromobutane	   (555	  μL,	   5.17	  mmol)	   in	   a	   high	  pressure	  
tube.	  The	  mixture	  was	  stirred	  at	  100	  ºC	  for	  12h.	  After	  removal	  of	  the	  volatiles	  under	  
reduced	   pressure	   the	   viscous	   precipitate	   was	   crystallized	   from	  
dichloromethane/diethyl	  ether.	  The	  oily	  residue	  was	  filtered	  and	  washed	  with	  diethyl	  
ether	  (3	  x	  5	  mL)	  to	  afford	  the	  imidazolium	  salt	  2	  as	  a	  hygroscopic	  white	  solid.	  Yield	  415	  
mg	  (50%).	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  11.10	  (s,	  1H,	  NCHN),	  8.16	  (s,	  1H,	  CHim),	  8.05	  (s,	  
4H,	  CHPh),	  7.81	  (s,	  1H,	  CHim),	  4.53	  (t,	  J	  =	  7.3	  Hz,	  2H,	  NCH2),	  2.56	  (s,	  3H,	  COCH3),	  2.03	  –	  
1.88	  (m,	  2H,	  CH2),	  1.39	  –	  1.26	  (m,	  2H,	  CH2),	  0.91	  (t,	  J	  =	  7.3	  Hz,	  3H,	  CH3).	  13C20	  NMR	  (300	  
MHz,	   CDCl3):	   δ	   196.4	   (COCH3),	   137.9,	   136.9,	   136.0,	   130.1,	   124.9,	   122.6,	   120.9	   (CHPh,	  
CHim),	   51.7	   (NCH2),	   33.5	   (CH2),	   27.0	   (COCH3),	   21.2	   (CH2),	   14.8	   (CH3).	   Not	   a	   proper	  
elemental	  analysis	  could	  be	  obtained	  due	  to	  the	  oily	  character	  of	  the	  imidazolium	  salt.	  
Electrospray	  MS	   (Cone	   20V)	   (m/z,	   fragment):	   243.0	   [M-­‐Br]+.	   Electrospray	  Ms.	   (Cone	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20V)	   (m/z,	   fragment):	   243.14	   [M-­‐Br]+.	   HRMS	   ESI-­‐TOF-­‐MS	   (positive	   mode):	   [M-­‐Br]+	  
monoisotopic	  peak	  243.1494;	  calc.	  243.1497,	  εr	  1.2	  ppm.	  
 
Synthesis	  of	   3.	   In	   a	  high	  pressure	   tube	  Cesium	  Carbonate	   (246	  mg,	   0.75	  mmol)	  was	  
added	  to	  a	  solution	  of	  the	  imidazolium	  salt	  1	  (105	  mg,	  0.32	  mmol)	  and	  [Cp*IrCl2]2	  (100	  
mg,	  0.13	  mmol)	   in	  acetonitrile	  (5	  mL).	  The	  mixture	  was	  heated	  at	  100	  °C	  for	  4	  hours.	  
After	   cooling,	   the	  mixture	  was	   filtered	   through	   a	   pad	   of	   celite	   and	   the	   solvent	   was	  
removed	  under	  reduce	  pressure.	  The	  crude	  solid	  was	  purified	  by	  crystallization	  from	  a	  
dichloromethane/hexane	   mixture	   giving	   a	   yellow	   powder.	   Yield	   140	   mg	   (95	   %).	   1H	  
NMR	  (300	  MHz,	  CDCl3):	  δ	  8.32	  (s,	  1H,	  CHPh),	  7.57	  (d,	  3JH-­‐H	  =	  1.9	  Hz,	  1H,	  CHPh),	  7.37	  (s,	  
1H,	  CHim),	  7.16	  (d,	  3JH-­‐H	  =	  1.9	  Hz,	  2H,	  CHPh),	  7.02	  (s,	  1H,	  CHim),	  3.90	  (s,	  3H,	  NCH3),	  2.62	  (s,	  
3H,	  COCH3),	  1.93	  (s,	  15H,	  Cp*).	  13C	  {1H}	  NMR	  (300	  MHz,	  CDCl3):	  δ	  198.3	  (COCH3),	  167.2	  
(Ccarbene),	   150.8	   (CPh-­‐Ir),	   142.1,	   133.3,	   134.8,	   123.0,	   122.8,	   115.4,	   110.3	   (CHPh,	   CHim),	  
91.3	   (CCp*),	   36.9	   (NCH3),	   26.8	   (COCH3),	   9.7	   (CH3,Cp*).	   Anal.	   Calcd.	   For	   C22H26N2OClIr	  
(562.1):	  C,	  47.00;	  H,	  4.66;	  N,	  4.98.	  Found:	  C,	  46.95;	  H,	  4.54;	  N,	  4.96.	  Electrospray	  MS	  
(Cone	  20V)	  (m/z,	  fragment):	  568.1	  [M-­‐Cl+MeCN]+.	  HRMS	  ESI-­‐TOF-­‐MS	  (positive	  mode):	  
[M-­‐Cl]+	  monoisotopic	  peak	  527.1680;	  calc.	  527.1675,	  εr	  0.9	  ppm.	  
	  
Synthesis	  of	  4. In	  a	  round	  bottom	  flask,	  covered	  with	  aluminum	  foil,	  silver	  oxide	  (31.4	  
mg,	  0.14	  mmol)	  and	  the	  imidazolium	  salt	  of	  2	  (78.0	  mg,	  0.24	  mmol)	  were	  dissolved	  in	  
dichlorometane	   (20	  mL).	   The	  mixture	  was	   stirred	   at	   room	   temperature	   for	   6	   hours.	  
Then,	  [Cp*IrCl2]2	  (100	  mg,	  0.13	  mmol)	  was	  added	  and	  the	  reaction	  was	  maintained	  at	  
room	  temperature	  for	  12	  hours.	  The	  mixture	  was	  filtered	  through	  a	  pad	  of	  celite	  and	  
the	   solvent	   was	   removed	   under	   reduce	   pressure.	   The	   crude	   solid	   was	   purified	   by	  
crystallization	  from	  a	  dichloromethane/hexane	  mixture	  giving	  an	  orange	  powder.	  Yield	  
125	  mg	  (86	  %).	  1H	  NMR	  (300	  MHz,	  CDCl3):	  δ	  8.32	  (s,	  1H,	  CHPh),	  7.63	  (d,	  3JH-­‐H	  =	  7.2	  Hz,	  
1H,	  CHPh),	  7.39	  (s,	  1H,	  CHim),	  7.17	  (d,	  3JH-­‐H	  =	  8.0	  Hz,	  1H,	  CHPh),	  7.05	  (s,	  1H,	  CHim),	  4.42	  –	  
4.39	  (m,	  1H,	  NCH2),	  4.19	  –	  4.15	  (m,	  1H,	  NCH2),	  2.63	  (s,	  3H,	  COCH3),	  1.79	  (s,	  15H,	  Cp*),	  
1.63	  –	  1.60	  (m,	  2H,	  CH2),	  1.46	  –	  1.42(m,	  2H,	  CH2),	  0.99	  (t,	  3JH-­‐H	  =	  7.3	  Hz,	  3H,	  CH3).	  13C	  
{1H}	   NMR	   (300	   MHz,	   CDCl3):	   δ	   198.3	   (COCH3),	   166.2	   (Ccarbene),	   150.6	   (CPh-­‐Ir),	   142.1,	  
138.0,	  134.7,	  124.1,	  121.1,	  105.3,	  109.9	  (CPh,	  CHim),	  91.2,	  (CCp*),	  50.1	  (NCH2),	  33.3	  (CH2),	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27.2	  (COCH3),	  20.2	  (CH2),	  13.9	  (CH3)	  9.7	  (CH3.Cp*).	  Anal.	  Calcd.	  For	  C25H32N2OClIr	  (604.2):	  
C,	  49.70;	  H,	  5.34;	  N,	  4.64.	  Found:	  C,	  49.31;	  H,	  5.48;	  N,	  4.76.	  Electrospray	  MS	  (Cone	  20V)	  
(m/z,	   fragment):	   610.2,	   [M	   -­‐	   Cl+MeCN]+.	   HRMS	   ESI-­‐TOF-­‐MS	   (positive	  mode):	   [M-­‐Cl]+	  
monoisotopic	  peak	  569.2145;	  calc.	  569.2142,	  εr	  0.5	  ppm. 
 
Synthesis	  of	  5.	  To	  a	  solution	  of	  4-­‐(chloromethyl)benzaldehyde	  (480	  mg,	  3.10	  mmol)	  in	  
dry	  THF	   (8	  mL)	  was	  added	  1-­‐methylimidazole	   (300	  μL,	   3.76	  mmol).	   The	  mixture	  was	  
stirred	   at	   60	   ºC	   for	   72h.	   After	   removal	   of	   the	   volatiles	   under	   reduced	   pressure	   the	  
viscous	  precipitate	  was	  extracted	  with	  dichloromethane	  (3	  x	  10	  mL).	  The	  imidazolium	  
salt	  5	  was	  obtained	  as	  colorless	  oil.	  Yield	  305	  mg	  (41%).	  1H	  NMR	  (300	  MHz,	  CD3CN):	  δ	  
10.02	  (s,	  1H,	  CHO),	  9.87	  (s,	  1H,	  NCHN),	  8.08	  (d,	  3JH-­‐H	  =	  8.0	  Hz,	  2H,	  CHPh),	  7.70	  (d,	  3JH-­‐H	  =	  
8.0	  Hz,	  2H,	  Ph),	  7.67	   (s,	  1H,	  CHim),	  7.54	   (s,	  1H,	  CHim),	  5.64	   (s,	  2H,	  NCH2),	  3.89	   (s,	  3H,	  
NCH3).	   13C	   {1H}	   NMR	   (75	   MHz,	   CD3CN):	   δ	   192.4	   (CHO),	   140.7,	   137.0,	   136.7,	   130.1,	  
129.2,	   124.1,	   122.3	   (CHPh,	   CHim,	   NCHN),	   52.0	   (NCH2),	   36.1	   (NCH3).	   Electrospray	   MS	  
(Cone	  20V)	  (m/z,	  fragment):	  201.4.	  [M-­‐Cl]+.	  HRMS	  ESI-­‐TOF-­‐MS	  (positive	  mode):	  [M-­‐Cl]+	  
monoisotopic	  peak	  201.1023;	  calc.	  201.1028,	  εr	  2.0	  ppm.	  
 
Synthesis	  of	  6.	  Following	  the	  same	  procedure	  as	  described	  for	  complex	  3	  using	  Cesium	  
Carbonate	   (165	   mg,	   0.51	   mmol),	   the	   imidazolium	   salt	   5	   (72	   mg,	   0.30	   mmol)	   and	  
[Cp*IrCl2]2	  (100	  mg,	  0.13	  mmol).	  Complex	  6	  was	  obtained	  as	  an	  orange	  solid.	  Yield	  101	  
mg	  (70	  %).	  1H	  NMR	  (300	  MHz,	  CD3CN):	  δ	  9.93	  (s,	  1H,	  CHO),	  8.02(s,	  1H,	  CHPh),	  7.37	  (d,	  
3JH-­‐H	  =	  7.6	  Hz,1H,	  CHPh),	  7.29	  (m,	  3H,	  CHPh,	  CHim),	  4.96	  –	  4.79	  (m,	  2H,	  NCH2),	  3.89	  (s,	  3H,	  
NCH3),	   2.01	   (m,	   15H,	   Cp*).	   13C	   {1H}	   NMR	   (75	   MHz,	   CD3CN):	   δ	   194.7	   (CHO),	   157.3	  
(Ccarbene),	   149.9	   (CPh-­‐Ir),	   147.7,	   144.8,	   136.2,	   125.7,	   123.5,	   122.8,	   121.7	   (CHPh,	   CHim),	  
91.3	   (CCp*),	   57.4	   (NCH2),	   37.3	   (NCH3),	   9.6	   (CH3,Cp*).	   Anal.	   Calcd.	   For	   C22H26N2OClIr	  
(562.1):	  C,	  47.00;	  H,	  4.66;	  N,	  4.98.	  Found:	  C,	  47.21;	  H,	  4.73;	  N,	  4.99.	  Electrospray	  MS	  
(Cono	  20V)	  (m/z,	  fragment):	  527.4.	  [M-­‐Cl]+.	  HRMS	  ESI-­‐TOF-­‐MS	  (positive	  mode):	  [M-­‐Cl]+	  




Synthesis	   of	   nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7). In	   a	   high	   pressure	   tube	   nano-­‐Fe3O4-­‐
dopa	  (570	  mg)	  was	  added	  to	  a	  solution	  of	  the	  iridium	  complex	  6	  (30	  mg,	  0.05	  mmol)	  in	  
toluene	  (5	  mL).	  The	  mixture	  was	  heated	  at	  100	  °C	  for	  20	  hours.	  After	  cooling,	  the	  solid	  
was	   separated	   using	   an	   external	   magnet,	   washed	   with	   toluene	   (3	   x	   5	   mL)	   and	  
dichlorometane	   (2	   x	   5	   mL)	   and	   dried	   under	   reduced	   pressure.	   The	   nano-­‐Fe3O4-­‐
dopa@Cp*IrNHC	  magnetic	  material	  (7)	  was	  obtained	  as	  a	  dark	  brown	  solid. 
 
Catalytic	   studies. General	   procedure	   for	   transfer	   hydrogenation:	   In	   a	   high	   pressure	  
tube	   were	   added	   the	   ketone	   (0.5	   mmol),	   Cs2CO3	   (1	   equiv.),	   anisole	   as	   internal	  
reference	  standard	  (0.5	  equiv.),	  catalyst	  (0.5	  mol%)	  and	  3	  mL	  of	  iPrOH	  used	  as	  solvent	  
and	  hydrogen	  donor.	  The	  tube	  was	  closed	  and	  the	  mixture	  was	  heated	  at	  100	  ºC	  for	  24	  
h.	   After	   cooling	   to	   room	   temperature	   the	   catalyst	   was	   separated	   using	   an	   external	  
magnet	   and	   the	   solution	   was	   filtered	   using	   celite	   and	   analyzed.	   Yields	   were	  
determined	  by	  GC	   analyses	   and	   products	  were	   identified	   according	   to	   spectroscopic	  
data	   of	   commercially	   available	   compounds.	   The	   recycling	   experiments	   were	   carried	  
out	   under	   identical	   reaction	   conditions.	   After	   completion	   of	   each	   run,	   the	   reaction	  
mixture	  was	  allowed	  to	  reach	  room	  temperature	  and	  the	  solid	  catalyst	  was	  separated	  
using	   an	   external	   magnet,	   washed	   with	   iPrOH	   (4	   x	   5	   mL),	   dried	   and	   reused	   in	   the	  
subsequent	  run. 
	  
Results	  and	  discussion	  	  
Synthesis	   and	   characterization:	   The	   imidazolium	   salts	   1	   and	   2	   were	   prepared	   by	  
alkylation	   of	   4ʹ′-­‐(imidazol-­‐1-­‐yl)acetophenone	   using	   iodomethane	   or	   1-­‐bromobutane	  
according	  to	  literature	  procedures.15	  The	  reaction	  of	  the	  imidazolium	  salts	  1	  or	  2	  under	  
basic	   conditions	   (Cs2CO3)	   in	   the	  presence	  of	   [Cp*IrCl2]2	   afforded	   the	  orthometallated	  
iridium	  complexes	  3	  and	  4	  in	  high	  yields,	  95%	  and	  86%	  respectively	  (Scheme	  1).	  Cp*Ir	  
complexes	   bearing	   an	   N-­‐heterocyclic	   carbene	   ligand	   with	   phenyl	   or	   benzyl	   wingtip	  
groups	  have	  a	  great	  tendency	  to	  orthometallate	  by	  C-­‐H	  activation,	  most	  probably	  due	  
to	  a	  chelate-­‐assisted	  process.21	  The	  imidazolium	  salt	  5	  was	  obtained	  by	  alkylation	  of	  1-­‐
methylimidazole	  using	  4-­‐(chloromethyl)benzaldehyde.	  The	  reaction	  of	  the	  imidazolium	  
salt	   5	   under	   the	   reaction	   conditions	   previously	   described	   afforded	   the	   six-­‐member	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cyclometallated	  iridium	  complex	  6	  (Scheme	  1).	  The	  iridium	  complexes	  obtained	  (3	  –	  6)	  
are	   air	   stable	   in	   the	   solid	   state	   and	   solution.	   The	   characterization	   of	   the	  molecular	  
complexes	   was	   performed	   by	   NMR,	   ESI/MS,	   HRMS	   and	   elemental	   analysis.	   The	   1H	  
NMR	  confirms	  that	  the	  NHC	  ligand	  metallation	  has	  occurred	  by	  the	  disappearance	  of	  
the	   C2-­‐H	   acidic	   proton.	   The	   13C	  NMR	   confirms	   that	  metallation	   has	   occurred	   by	   the	  
characteristic	   C-­‐carbene	   signal	   at	  δ	   167.2	   (complex	  3),	   166.2	   (complex	  4)	   and	   157.3	  
(complex	  6).	   The	  nature	  of	   the	   iridium	  complexes	  was	   further	  analyzed	  by	  means	  of	  
electrospray	  mass	  spectrometry	   (ESI/MS)	  based	  on	  the	  mass/charge	  relation	  and	  the	  
isotopic	  pattern	  distribution.	  Positive	  ion	  electrospray	  mass	  spectra	  analysis	  show	  base	  
peaks	  for	  [M-­‐Cl+MeCN]+	  at	  m/z	  =	  568.2	  for	  3,	  [M-­‐Cl+MeCN]+	  at	  m/z	  =	  610.2	  for	  4	  and	  
[M-­‐Cl]+	  at	  m/z	  =	  527.4	  for	  6.	  High	  resolution	  mass	  spectrometry	  (HRMS)	  confirmed	  the	  
exact	  mass	  with	  relative	  errors	  lower	  than	  2	  ppm.	  
 
 
Scheme	  1.	  Synthesis	  of	  Cp*IrNHC	  complexes.	  
The	  molecular	  structure	  of	  complex	  3	  was	  confirmed	  by	  single	  crystal	  X-­‐ray	  diffraction.	  
(Figure	   1).	   Single	   crystals	   were	   obtained	   by	   slow	   diffusion	   of	   hexane	   into	   a	   high	  
concentrated	   solution	   of	  3	   in	   dichloromethane.	   Complex	  3	   crystallizes	   in	   the	   achiral	  
space	  group	  P-­‐1	  and	  contains	  a	  single	  molecule	  in	  the	  asymmetric	  unit.	  The	  geometry	  
of	  the	  complex	  is	  the	  expected	  three-­‐legged	  piano-­‐stool	  with	  dihedral	  angles	  close	  to	  
90	  degrees	  except	  the	  C(3)	  -­‐	  Ir(1)	  -­‐	  C(10)	  of	  77.44(18)°	  due	  to	  the	  chelate	  coordination	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of	   the	   NHC-­‐phenyl	   ligand.	   The	   C-­‐C	   orthometallated	   NHC-­‐phenyl	   ligand	   forms	   a	   five-­‐
member	  ring	  in	  a	  planar	  conformation.	  The	  iridium	  distances	  are	  Ir(1)-­‐	  C(3)	  2.000(4)	  Å,	  
Ir(1)	  -­‐	  C(10)	  2.055(4)	  Å	  and	  Ir(1)	  -­‐	  C(12)	  2.4583	  (4)	  Å	  and	  lie	  in	  the	  expected	  range	  for	  
Cp*Ir(NHC)	  complexes.	  
 
Figure	   1.	   Molecular	   diagram	   of	   complex	   3.	   Ellipsoids	   are	   at	   50%	   probability	   level.	  
Hydrogen	  atoms	  omit	  for	  clarity.	  Selected	  bond	  lengths	  [Å]	  and	  angles	  [º]:	   Ir(1)	  -­‐	  C(3)	  
2.000(4),	  Ir(1)	  -­‐	  C(10)	  2.055(4),	  Ir(1)	  -­‐	  Cl(2)	  2.4583(10),	  C(3)	  -­‐	  Ir(1)	  -­‐	  C(10)	  77.44(18),	  C(3)	  




Scheme	  2.	  Condensation	  reaction	  of	  Cp*IrNHC-­‐CHO	  (6)	  with	  the	  nano-­‐Fe3O4-­‐dopa	  
The	   magnetite	   nano-­‐Fe3O4	   functionalized	   with	   dopamine	   (nano-­‐Fe3O4-­‐dopa)	   was	  
synthesized	   according	   to	   Varma’s	   method.17	   The	   Cp*Ir	   molecular	   complex	   (6)	   was	  
covalently	   anchored	   on	   the	   surface	   of	   the	   magnetic	   nanoparticles	   by	   condensation	  
(Scheme	  2).	  The	  reaction	  of	  the	  orthometalated	  iridium	  complex	  bearing	  an	  NHC-­‐CHO	  
functionalized	   ligand	  (6)	  with	  the	  amine	  groups	  of	   the	  nano-­‐Fe3O4-­‐dopa	  afforded	  the	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nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  magnetic	  material	   (7).	   After	   20	   h	   reaction	   the	  material	  
was	  washed	   thoroughly	  with	   toluene	  and	  dichlorometane.	  The	  exact	   iridium	  content	  
on	  7	  was	  determined	  by	  ICP-­‐MS	  analysis.	  The	  results	  obtained	  accounted	  for	  a	  2.7	  wt%	  
of	  the	  molecular	  complex	  6	  in	  the	  material	  7.	  The	  characterization	  of	  the	  materials	  was	  
performed	   using	   XRD,	   FTIR	   and	   HRTEM	   (See	   supplementary	   data	   for	   details).	   The	  
HRTEM	   analysis	   of	   7	   shows	   the	   presence	   of	   Fe3O4	   spherical	   nanoparticles	   of	   a	   size	  
range	  20	  –	  30	  nm	  (Figure	  2).	  The	  HRTEM	  analysis	  before	  and	  after	  the	  functionalization	  
with	   the	   iridium	   complex	   reveals	   that	   shape	   and	   size	  of	   the	   Fe3O4	  nanoparticles	   are	  
preserved	  after	  the	  condensation	  reaction	  (Compare	  Figure	  2	  and	  Figures	  S1	  –	  S3).	  	  
 
Figure	  2.	  HRTEM	  images	  at	  different	  magnification	  showing	  the	  spherical	  morphology	  
of	  the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7).	  
 
 
Scheme	  3.	  Condensation	  reaction	  of	  Cp*IrNHC-­‐CHO	  (6)	  with	  benzylamine.	  
In	  order	  to	  confirm	  that	  the	  condensation	  reaction	  is	  the	  responsible	  for	  the	  anchoring	  
of	  the	  iridium	  complex	  on	  the	  surface	  of	  the	  nano-­‐Fe3O4-­‐dopa,	  we	  performed	  a	  control	  
experiment	   (Scheme	   3).	   In	   this	   experiment	   the	   Cp*IrNHC-­‐CHO	   complex	   (6)	   was	  
condensed	   with	   benzylamine	   under	   exactly	   the	   same	   reactions	   conditions.	   The	  
characterization	   of	   the	   condensed	   iridium	   complex	   (8)	   was	   performed	   by	  means	   of	  
ESI/MS	   and	   HRMS.	   Positive	   ion	   electrospray	   mass	   spectra	   analysis	   after	   the	  
condensation	  reaction	  reveals	  the	  presence	  of	  two	  intense	  peaks	  for	  [M-­‐Cl]+	  at	  m/z	  =	  
527.2	  and	  617.2.	  These	  two	  peaks	  correspond	  to	  the	  presence	  of	  complexes	  6	  and	  8	  
respectively,	   just	   confirming	   that	   the	   condensation	   reaction	   is	  not	  quantitative.	  High	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resolution	  mass	   spectrometry	   (HRMS)	   confirmed	   the	   exact	   mass	   of	   complex	   8	   with	  
relative	  errors	  inferior	  to	  1	  ppm.	  When	  the	  same	  experiment	  was	  carried	  out	  using	  the	  
Cp*IrNHC-­‐COCH3	   complexes	   (3)	   and	   (4),	  we	  observed	   that	   no	   condensation	   reaction	  
occurred.	  
The	  catalytic	  activity	  of	  the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7)	  was	  evaluated	  in	  transfer	  
hydrogenation.22	   The	   Cp*Ir	   type	   complexes	   have	   extensively	   been	   evaluated	   as	  
homogeneous	   catalysts	   in	   the	   reduction	   of	   ketones	   and	   imines	   under	   transfer	  
hydrogenation	  conditions.23	  The	  reactions	  were	  carried	  out	  using	  iPrOH	  as	  solvent	  and	  
hydrogen	  donor	  in	  the	  presence	  of	  stoichiometric	  amounts	  Cs2CO3	  and	  using	  a	  catalyst	  
loading	   of	   0.5	  mol%,	   under	   aerobic	   conditions	   and	   using	   regular	   solvents.	   (Table	   1).	  
The	   catalytic	   activity	   of	   the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7)	  was	   compared	  with	   the	  
molecular	   iridium	   complex	   (6).	   In	   both	   catalytic	   systems	   the	   addition	   of	   base	   is	  
required	   for	   the	   formation	   of	   the	   catalytic	   active	   species,	   as	   has	   previously	   been	  
described.24	   In	   the	   development	   of	   this	   work,	   we	   wanted	   to	   use	   complex	   8	   as	   an	  
analogue	   for	   the	   magnetite-­‐immobilized	   complex	   and	   all	   our	   efforts	   persuade	   the	  
isolation	  and	  purification	  of	   the	  complex.	  Unfortunately	  complex	  8	  was	  not	  obtained	  
pure	  enough	   for	   catalyst	   testing	  and	  complex	   (6)	  was	  used	   instead.	   For	   comparative	  
purposes,	   a	   table	   in	   the	   supplementary	   information	   shows	   the	   catalytic	   activity	   of	  
different	  Cp*Ir	  complexes	  in	  the	  reduction	  of	  acetophenone	  by	  transfer	  hydrogenation	  
(Table	  S7). 
	  
In	   a	   first	   experiment	   the	   catalytic	   activity	   of	   the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  
(7)	  and	  the	  molecular	  iridium	  complex	  (6)	  was	  compared	  in	  the	  transfer	  hydrogenation	  
of	  acetophenone	  (Figure	  3).	  The	  comparative	  reaction	  profile	  shows	  that	  there	   is	  not	  






Figure	  3.	  Comparative	  reaction	  profile	  in	  the	  transfer	  hydrogenation	  of	  acetophenone	  
using	   the	   molecular	   catalyst	   (6)	   and	   the	   nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7).	   Reaction	  
conditions:	   0.5	  mmol	   of	   acetophenone,	   Cs2CO3	   (1	   Eq),	   catalyst	   (0.5	  mol	  %),	   3	  mL	   of	  
iPrOH	   for	   24	   hours	   at	   100	   ºC.	   Yields	   determined	   by	   GC	   analyses	   using	   anisole	   as	  
internal	  standard.	  
 
The	   molecular	   complex	   6	   is	   active	   in	   the	   reduction	   of	   ketones	   yielding	   the	  
corresponding	   alcohols	   in	   quantitative	   yields	   after	   24	   hours	   reaction	   at	   100	   ºC.	   The	  
same	  catalytic	  activity	  was	  obtained	  when	  using	   the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7)	  
material	  under	  the	  same	  reaction	  conditions	  and	  metal	  amount.	  This	   is	  an	   indication	  
that	   the	   support	   does	   not	   have	   any	   influence	   in	   the	   catalytic	   process.	   When	   the	  
reaction	   was	   carried	   out	   without	   catalyst	   or	   using	   nano-­‐Fe3O4-­‐dopa	   as	   catalyst	   the	  
yields	   were	   less	   than	   5%	   (entries	   1,	   2	   and	   5).	   These	   experiments	   reveal	   that	   the	  
Cp*IrNHC	   fragment	   is	   the	   responsible	   of	   catalytic	   process.	   Acetophenone	   was	  
converted	   into	   1-­‐phenyl	   ethanol	   in	   90%	   yield	   by	   using	   catalyst	   6.	   When	   the	   same	  
reaction	  was	   carried	  out	  using	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7)	   the	  yield	  of	  1-­‐phenyl	  
ethanol	   was	   93%	   (entries	   3	   –	   4).	   Introduction	   of	   different	   electron	  
withdrawing/donating	  groups	  does	  not	  have	  much	  influence	  in	  the	  catalytic	  outcomes	  
(entries	  6	  –	  9).	  When	  increasing	  the	  sterics	  of	  substrates	  the	  molecular	  complex	  6	  gave	  
slightly	   better	   results	   than	   the	   catalytic	   material	   (entries	   10	   –	   13).	   Both	   catalytic	  
systems	  are	  moderately	  active	  in	  the	  reduction	  of	  aliphatic	  ketones	  (entries	  14	  –	  15).	  A	  
list	  of	  comparative	  Cp*Ir	  catalysts	  activity	  in	  transfer	  hydrogenation	  of	  acetophenone	  








Table	  1	   Transfer	  Hydrogenation	  using	   the	  molecular	   complex	  6	   and	   the	  NHC-­‐Ir-­‐MNP	  
(7).a	  
 




2 Fe3O4dopa < 5% 
3 6 90 




6 6 98 
















15 7 99 
[a]	  Reactions	  were	  carried	  out	  with	  0.5	  mmol	  of	  substrate,	  Cs2CO3	  (1	  Eq),	  catalyst	  (0.5	  
mol	  %),	  3	  mL	  of	   iPrOH	   for	  24	  hours	  at	  100	  ºC.	   [b]	  Yields	  determined	  by	  GC	  analyses	  
using	  anisole	  as	  internal	  standard.	  
 
In	  view	  of	   the	   results	  obtained	   in	   the	   transfer	  hydrogenation,	  we	  decided	  to	  explore	  
the	   catalyst	   stability	   by	   exploring	   the	   catalyst	   recovery	   and	   reuse.	   Recycling	  
experiments	  of	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7)	  were	  carried	  out	  using	  acetophenone,	  
cyclohexanone,	   p-­‐bromoacetophenone	   and	   p-­‐methoxyacetophenone	   (Figure	   4).	   The	  
reaction	   conditions	  were	   the	   same	  as	   those	  described	   in	   the	   transfer	  hydrogenation	  
process	  described	  in	  Table	  1.	  After	  completion	  of	  each	  run	  (24	  h.),	  the	  reaction	  mixture	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was	  allowed	   to	   reach	   room	   temperature,	   and	   the	   solid	   catalyst	  was	   separated	  using	  
and	  external	  magnet	  (Figure	  S8),	  washed	  with	  iPrOH	  (4	  x	  5	  mL),	  dried	  and	  reused	  in	  the	  
subsequent	  run.	  Following	  this	  methodology	  the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7)	  was	  
reused	   for	   two	   times	  without	   any	   decrease	   of	   activity	   in	   the	   case	   of	   acetophenone.	  
Then,	  the	  catalytic	  activity	  decrease	  to	  50%	  yield	  and	  is	  maintained	  up	  to	  the	  fifth	  run.	  
In	  the	  case	  of	  the	  other	  substrates,	  the	  catalyst	  activity	  is	  maintained	  for	  two	  runs,	  and	  
then	   a	   dramatic	   decrease	   in	   activity	   was	   observed,	   except	   in	   the	   case	   of	   the	   p-­‐
methoxyacetophenone	   were	   after	   the	   first	   catalytic	   run	   the	   catalyst	   activity	   is	  
completely	  lost.	  These	  results	  suggest	  a	  deactivation	  of	  the	  molecular	  iridium	  complex	  
anchored	  on	  the	  surface	  of	  the	  nano-­‐Fe3O4-­‐dopa.	  The	  deactivation	  process	  is	  substrate	  
dependent.	   In	   order	   to	   increase	   the	   recyclability	   of	   the	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  
(7)	  we	  performed	  a	  recycling	  experiment	  using	  acetophenone	  under	  inert	  conditions.	  
The	  results	  were	  the	  same	  as	  using	  aerobic	  conditions	  and	  the	  catalyst	  activity	  drops	  to	  
50%	  after	  the	  second	  catalytic	  run.	  Then	  we	  analyze	  the	  catalytic	  material	  by	  means	  of	  
HRTEM	  analysis	  (Figure	  5).	  The	  results	  show	  that	  after	  three	  catalytic	  runs	  the	  size	  and	  
morphology	   of	   the	   nano-­‐Fe3O4	   are	   preserved	   and	   no	   degradation	   of	   the	  material	   is	  
observed.	  	  
 
Figure	  4.	  Recycling	  experiments	  in	  transfer	  hydrogenation	  using	  Cp*IrNHC@NPsFe3O4	  
(7)	  as	  catalyst.	  Reaction	  conditions:	  0.5	  mmol	  of	  substrate,	  Cs2CO3	  (1	  Eq),	  catalyst	  (0.5	  
mol	  %),	  3	  mL	  of	  iPrOH	  for	  24	  hours	  at	  100	  ºC	  for	  each	  run.	  Yields	  of	  the	  corresponding	  




Figure	  5.	  HRTEM	  images	  at	  different	  magnification	  of	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7)	  
after	  three	  catalytic	  runs	  using	  acetophenone	  as	  substrate.	  
The	   poor	   recyclability	   of	   the	   nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7)	   could	   be	   attributed	   to	  
the	   attachment	   of	   the	  molecular	   complex	  6	   by	   an	   imine	   formation.	   In	   principle,	   the	  
imine	  functionality	  is	  hydrolytically	  unstable	  and	  liable	  to	  break	  under	  basic	  conditions.	  
In	   order	   the	   check	   this	   hypothesis	   the	   amount	   of	   iridium	   leaching	   was	   analyzed	   by	  
ICP/MS	   analysis	   in	   the	   recycling	   experiment	   using	   acetophenone	   as	   substrate.	   The	  
results	   reveal	   that	   the	   amount	   of	   iridium	   is	   negligible	   in	   five	   consecutive	   runs,	   just	  
indicating	   that	  decoordination	  of	   the	  molecular	   complex	  6	  by	   imine	  hydrolysis	   is	  not	  
occurring.	  These	  results	  are	  supported	  by	  other	  examples	  previously	  developed	  by	  our	  
group	   14f	   and	   others23h,	   25	   where	   imines	   are	   not	   hydrolyzed	   under	   transfer	  
hydrogenation	   conditions	  using	   strong	  bases.14b,	   14d,	   26	   The	   transfer	  hydrogenation	  of	  
imines	  using	   iPrOH	  as	   solvent	  and	  hydrogen	  donor	   in	   the	  presence	  of	   stoichiometric	  
amounts	   Cs2CO3	   has	   been	   successfully	   achieve	   with	   iridium	   and	   rhodium	   N-­‐
heterocyclic	   carbene	   complexes	   without	   any	   detectable	   hydrolysis	   product	  
formation.25f	  
Other	   important	   factor	   related	   to	   supported	   catalysis	   is	   the	   so	   called	  
“boomerang	  effect”	  or	  “release	  and	  catch”	  catalytic	  systems.27	  This	  effect	  consists	  in	  a	  
release-­‐and-­‐return	  of	  the	  molecular	  complex	  form	  the	  support,	  therefore	  implying	  that	  
the	   catalytic	   process	   is	   carried	   out	   homogeneously	   and	   then	   the	   catalytic	   active	  
species	  are	  “caugh”	  at	  the	  end	  of	  the	  reaction	  by	  the	  support.	  The	  imine	  hydrolysis	  of	  
the	  material	  nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	  (7)	  could	  yield	  the	  corresponding	  aldehyde	  
(molecular	  complex	  6)	  and	  the	  amine	  (nano-­‐Fe3O4-­‐dopa).	  Note	  that	  this	  process	  is	  an	  
equilibrium	   reaction	   and	   could	   go	   back	   to	   the	   condensation	   product	   (nano-­‐Fe3O4-­‐
dopa@Cp*IrNHC	  (7)).	  A	  hot	  filtration	  experiment	  was	  realized	  in	  order	  to	  determine	  if	  
the	  boomerang	  effect	  is	  governing	  the	  catalytic	  process.	  The	  hot	  filtration	  experiment	  
was	  carried	  out	  using	  the	  general	  conditions	  described	  in	  table	  1	  using	  acetophenone	  
16	  
	  
as	   substrate	   and	   nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7)	   as	   catalyst.	   After	   6h	   reaction,	   the	  
catalyst	  was	  separated	  from	  the	  solution	  by	  using	  an	  external	  magnet	  at	  100	  ºC.	  At	  this	  
point,	  an	  aliquot	  was	  analyzed	  by	  GC	  and	  the	  yield	  of	  1-­‐phenyl	  ethanol	  was	  38%.	  The	  
filtrate	  was	  further	  heated	  at	  100	  ºC	  for	  18	  h	  and	  then	  analyzed.	  The	  results	  reveal	  that	  
no	   further	   alcohol	   is	   formed	   (GC	   final	   yield	   is	   maintained	   in	   38%).	   This	   experiment	  
suggests	  the	  absence	  of	  catalytic	  active	  species	  in	  solution	  due	  to	  imine	  hydrolysis.	  
 Cp*Ir	   type	   complexes	   have	   been	   used	   as	   homogeneous	   catalysts	   in	   the	  
reduction	  imines	  under	  transfer	  hydrogenation	  conditions.28	  The	  presence	  of	  an	  imine	  
in	   the	   supported	   catalyst	   nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7)	   could	   lead	   to	   the	  
hydrogenation	   of	   the	   imine	   producing	   the	   modification	   of	   the	   parent	   catalyst.	   The	  
formation	   of	   the	   corresponding	   amine	   should	   not	  modify	   the	   catalytic	   properties	   of	  
the	  system.	  To	  check	  the	  possibility	  of	  imine	  hydrogenation	  a	  control	  experiment	  was	  
carried	   out	   using	  N-­‐benzylideneaniline	   as	  model	   substrate.	   The	   reaction	  was	   carried	  
out	   using	   iPrOH	   as	   solvent	   in	   the	   presence	   of	   stoichiometric	   amounts	   Cs2CO3	   and	   a	  
catalyst	   loading	   of	   0.5	  mol%.	   The	   results	   reveal	   that	   the	  N-­‐benzylideneaniline	   is	   not	  
hydrogenated	   to	   the	   corresponding	   amine	   just	   indicating	   that	   the	   iridium	   catalyst	   is	  
not	  active	  in	  the	  hydrogenation	  of	  imines	  under	  this	  reaction	  conditions.	  We	  have	  also	  
observed	  that	  the	  N-­‐benzylideneaniline	  is	  recovered	  quantitatively,	   indicating	  that	  no	  
hydrolysis	  has	  occurred.	   
	   Based	  on	  the	  previous	  experiments	  the	  most	  plausible	  mechanism	  for	  the	  poor	  
recyclability	   of	   the	   supported	   nano-­‐Fe3O4-­‐dopa@Cp*IrNHC	   (7)	   catalyst	   in	   transfer	  
hydrogenation	  could	  be	  attributed	  to	  the	  formation	  of	  inactive	  iridium	  species	  that	  are	  
not	  catalytically	  active.	  The	  nature	  of	  this	  species	  is	  unknown	  but	  they	  are	  attached	  to	  
the	  magnetite	  and	  no	  release	  to	  solution	  has	  been	  observed.	  The	  situation	  is	  similar	  to	  
the	   catalyst	   activity/deactivation	   procedure	   observed	   for	   the	   molecular	   complexes.	  
Development	   of	   highly	   active	   and	   stable	   molecular	   catalysts	   should	   increase	   the	  




We	   have	   described	   a	   synthetic	   modular	   methodology	   that	   allowed	   us	   to	   obtain	  
catalytic	   materials	   based	   on	   magnetic	   nanoparticles	   with	   iridium-­‐N-­‐heterocyclic	  
carbene	  (NHC)	  complexes.	  Imidazolium	  salts	  containing	  a	  ketone/aldehyde	  as	  pendant	  
functional	  group	  have	  been	  synthesized.	  Metallation	  of	  the	  imidazolium	  salts	  leads	  to	  
17	  
	  
molecular	   Cp*iridium	   complexes.	   The	   condensation	   reaction	   of	   the	   Cp*IrNHC-­‐CHO	  
with	   magnetic	   nanoparticles	   containing	   amine	   groups	   on	   the	   surface	   yields	   the	  
covalent	  anchoring	  of	  the	  iridium	  complex	  to	  the	  surface	  of	  the	  magnetite.	  The	  iridium	  
complexes	   and	   the	   material	   are	   active	   in	   the	   reduction	   of	   ketones	   under	   transfer	  
hydrogenation	  conditions.	  The	  catalytic	  results	  reveal	  that	  the	  catalytic	  activity	  of	  the	  
material	  and	  the	  molecular	  complex	  is	  equivalent.	  We	  have	  not	  observed	  any	  change	  
in	   activity	   due	   to	   the	   support.	   The	   recyclability	   properties	   of	   the	  magnetic	  material	  
have	  been	  evaluated.	  The	  results	  show	  that	  the	  catalyst	  activity	  is	  maintained	  for	  two	  
runs.	   This	   work	   describes	   a	   simple	   methodology	   for	   the	   anchoring	   of	   molecular	  
complexes	   on	   the	   surface	   of	   magnetic	   nanoparticles	   by	   the	   formation	   of	   an	   imine.	  
Further	   research	   into	   the	   preparation	   of	   new	   catalytic	  materials	   following	   the	   same	  
methodology	  but	  with	  the	  formation	  of	  an	  amine	  or	  amide	  to	  improve	  the	  attachment	  
with	  the	  support	  is	  currently	  underway	  in	  our	  laboratory.	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